Figure 4From: Updated survivals and prognostic factor analysis in myeloma treated by a staged approach use of bortezomib/thalidomide/dexamethasone in transplant eligible patientsImpact of advanced (green line) and limited ISS stage (blue line) on OS, showing inferior survival in patients with advanced ISS stage.Back to article page